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Abstract: The genus Helichrysum Mill comprises hundreds of species that are mostly flowering
perennial shrubs. Some of these plants that belong to the Helichrysum species are used in traditional
medicine to treat cough, back pain, diabetes, asthma, digestive problems, menstrual pain, chest
pain, kidney disorders, skin disorders, wounds, open sores, among other conditions, but, only a
few scientific studies are reported in the literature with sufficient information that validates the
acclaimed folkloric benefits of these plants. This review, therefore, provides a comprehensive update
of the available information on the cytotoxicity, genotoxicity, anti-proliferative, anti-bacterial, anti-
fungal, anti-viral, anti-HIV, anti-malarial, anti-ulcerogenic, anti-tyrosinase, anti-inflammatory, and
anti-oxidant activities of selected Helichrysum species of interest: H. petiolare, H. cymocum, H. foetidum,
and H. pandurifolium Schrank, using scientific databases as well as electronic and print sources. The
ethnobotanical and morphological characteristics as well as the phytochemical composition and
biological activities of these plants are elucidated. The scientific rationale for their current use is
discussed based on the evidence in the literature. This review highlights the putative use of the
Helichrysum species as a reliable source of bioactive compounds for the production of standard
commercial drugs to treat many ailments, including those reported in folkloric uses. Further research
on the many plants in the genus Helichrysum is recommended to explore their economic importance
both as edible crops and medicinal botanicals.
Keywords: medicinal plants; phytochemicals; pharmacological actions; Helichrysum species
1. Introduction
The genus Helichrysum Mill comprises distinctively of aromatic herbs and shrubs of
the family Asteraceae. It has a worldwide distribution but is mainly found in Africa, with its
highest diversity in South Africa, where approximately 245 of the 500 known species occur.
Other areas of Helichrysum diversity include Europe, southwestern Asia, South India, Sri
Lanka, Turkey, and Australia. For ease of identification, the southern African species are
divided into 30 informal groups [1].
Plants of the Helichrysum genus have been in use for more than 2000 years for various
folkloric purposes. The flowers of some members of this genus have a unique bright-yellow
color that depicts their Greek language origins: “helios” and “chryos” which mean “sun”
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and “gold” respectively. In folkloric medicine, some Helichrysum plant parts are either
consumed as teas or prepared as “burnt offering” smoke to disinfect the abodes of sick
patients and to appeal for blessings from the ancestors in indigenous traditional practices [2].
In general, plants of this genus are known to be used in traditional medicine for the
treatment of many ailments, including liver disorders, gall bladder complications, cystitis,
jaundice, stomach pain, allergies, infections, colds, cough, skin infections, inflammation,
menstrual pain, asthma, arthritis, insomnia, diabetes mellitus, and for wound healing [3–7],
most commonly, the scented leaves and flowers.
The therapeutic properties of the Helichrysum species are often attributed to their
different constituent phytochemicals, especially the essential oils [8,9]. In addition to the
essential oils, plants in this species also contain such phytochemicals as terpenoids, pheno-
lics and oxygenated compounds as secondary metabolites, including flavonoids, chalcones,
phenolic acids, terpenes and essential oils, pyrone, benzofurans, and phloroglucinols [10].
Thus, these plants are potential reservoirs of bioactive compounds for drug discovery and
development. Hitherto, only limited biological effects of the Helichrysum phytochemicals
have been reported including, the antioxidant, antifungal, anti-inflammatory, anti-bacterial,
hepatoprotective, anti-proliferative and anti-diabetic activities [7,11–13].
So far, only a few of the many Helichrysum species have been studied; the best known
Helichrysum species used traditionally to treat different ailments are H. cymosum, H. odoratis-
simum, H. petiolare and H. nudifolium. Only limited information is available in the literature
on these plant species on their ornamental, industrial and pharmaceutical applications [14].
Thus, in this review, peer-reviewed information on Helichrysum petiolare Hilliard & B. L
Burtt, Helichrysum cymosum (L.) D.Don, Helichrysum foetidum (L.). Moench and Helichrysum
pandurifolium Schrank from South Africa will be elaborated, including their botanical,
ethnopharmacological, phytochemical and bio-scientific profiles.
2. Research Methodology
The keywords relevant to this review, including “Helichrysum species” “Helichrysum
petiolare Hilliard & B. L Burtt”, “Helichrysum cymosum (L.) D. Don”, “Helichrysum foetidum
(L). Moench”, “Helichrysum pandurifolium Schrank”, “cytotoxicity”, “anti-genotoxicity”,
“anti-proliferative”, “anti-bacterial”, “anti-fungal”, “anti-viral”, “anti-malarial”, “anti-
ulcerogenic”, “anti-tyrosinase”, “anti-inflammatory”, “antioxidant”, “phytochemicals”,
“ethnopharmacology” and “essential oil” were searched for, using different databases
including Sci Finder, ISI Web of Knowledge, Science Direct, Google Scholar, PubMed,
Scopus, Wiley Online Library and Springer; while online theses, dissertations, and other
print materials also provided important information on the traditional use, bioactive
phytochemical compositions, biological and pharmacological actions, as well as leads on
relevant gaps in research and future directions.
3. Helichrysum petiolare and Its Biological Activities
Helichrysum petiolare (H. petiolare) is commonly referred to as “Silverbush everlasting
plant”, and called “kooigoed” in the Afrikaans language of South Africa. This plant is
a shrub with gray or silver-gray hair covering the aromatic round-shaped leaf, while its
flowers are whitish-creamy [15]. H. petiolare is used in South African traditional medicine
to treat fever, catarrh, cold, cough, menstrual disorders, kidney-related infections, chest
problems, high blood pressure, and erectile dysfunction. In addition, the decoction of the
leaves of the plant is used in traditional beauty therapy to refine skin texture/looks and for
wound healing [16]. The known phytochemicals present in H. petiolare include phenols,
flavonoids, and anthocyanins, the extract and its essential oil constituents were reported
to show activity against Gram-positive and Gram-negative bacteria [17]. Other biological
activities of this plant are discussed below.
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3.1. Cytotoxicity/Anti-Proliferative Activity of H. petiolare
The in vitro cytotoxic effects of the chloroform and methanol leaf and stem extracts
of H. petiolare (1:1 solvent ratio) on transformed kidney epithelial (Graham’s) cells, breast
cancer cells (MCF-7) and brain cancer (SF-268) cells were studied using the sulforhodamine
B (SRB) assay and the results showed percentage growth inhibition of 59%, 33% and
76% for the Graham’s, MCF-7, and SF-268 cell lines, respectively [18]. In another study,
B16F10 mouse melanoma cells and MeWo human skin melanoma cells were treated with
the methanol extract of H. petiolare, and the cytotoxicity and cell cycle analysis showed a
dose-dependent reduction in cell viability or proliferation, as well as S-phase and M-phase
cell cycle arrest, reflecting pro-apoptotic effects.
3.2. Anti-Bacterial Activity of H. petiolare
The anti-bacterial activities of nine Helichrysum species of South African origin, in-
cluding H. petiolare, have been reported in such bacterial strains as Escherichia coli, Yersinia
enterocolytica, Klebsiella pneumomiae (Gram-positive) and Staphylococcus aureus and Bacillus
cereus (Gram-negative), using disc diffusion assay, with the standard drug neomycin as
control [19]. When compared with the control, the methanol and acetone extracts of H.
petiolare showed significant activities against S. aureus and B. cereus strains while the es-
sential oils showed no activity against these two bacterial strains. The zone of inhibition
is a uniformly circular area on an antibiotic dish that has no bacterial growth [20]. In the
study under reference, the inhibition zone values ranged between 2.5 mm to 9.0 mm in the
methanol and acetone extract-treated dishes compared with the 6 mm zone of inhibition in
the standard drug. The Gram-positive bacteria were unaffected following treatment with
the essential oil as well as the methanol and acetone extract of H. petiolare. Furthermore,
the minimum inhibitory concentration (MIC) assay was used as a confirmatory test for
the disc diffusion assay, and the results of this assay showed much improved activity for
both the methanol and acetone extracts (<0.25 mg/mL) of H. petiolare when compared with
the standard drug ciprofloxacin (0.31 × 10−3 mg/mL). However, the MIC assay showed a
relatively low activity of the essential oil treatment (8 mg/mL) on the S. aureus bacterial
strain [19].
In another study, Lourens and co-workers reported on the anti-bacterial effects of the
methanol and chloroform (1:1 solvent ratio) extracts of H. petiolare on five bacterial strains,
namely B. cereus, S. aureus, S. epidermidis, (Gram-positive), K. pneumomiae, and P. aeruginosa
(Gram-negative), with ciprofloxacin as the positive control. The results showed minimum
anti-bacterial effects against S. aureus and B. cereus with a MIC value of 4 mg/mL and
2 mg/mL respectively, compared to the control. However, no anti-bacterial activity was
recorded against the remaining bacterial strains in the 96-well microplate assay [21].
3.3. Anti-Inflammatory Activity of H. petiolare
Louren and co-workers investigated the anti-inflammatory properties of the essential
oil of H. petiolare using the 5-lipoxygenase assay, and the half-maximal inhibitory concen-
tration (IC50) value of 23.05 ± 0.57 µg/mL was obtained for the varying concentrations of
hydro-distilled essential oils, indicating potent anti-inflammatory effects. In comparison,
the positive control had an IC50 value of 5.0 ± 0.50 µg/mL while the methanol and acetone
extract of H. petiolare showed no anti-inflammatory activity, with an IC50 value greater than
100 µg/mL [21].
3.4. Anti-Fungal Activity of H. petiolare
Three strains of human fungi namely, Cryptococcus neoformanas, Candida albicans and
Alternaria alternate, were evaluated using the disc diffusion assay. The results showed
that only the acetone extract of H. pertiolare showed moderate anti-fungal activity against
C. albican compared with the standard drug Nystatin. In contrast, the essential oil and
methanol extract had no anti-fungal activity in the three fungal strains tested [21].
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3.5. Anti-Oxidant Activity of H. petiolare
A slight modification of the 1,1 diphenyl -2- picrylhydrazyl (DPPH) free radical
scavenging assay [20] was used to determine the anti-oxidant activity of the extracts of
H. petiolare, in reference to the ascorbic acid standard. The results of treatment with the
IC50 values of 44.28 µg/mL, 28.70 µg/mL and 2.5 µg/mL of the acetone and methanol
extracts as well as the ascorbic acid standard, respectively, showed that more than 50% of
the free radicals was inhibited or neutralized.
3.6. Antigenotoxicity Activity of H. petiolare
The results from one study showed genotoxic effects of the methanol extracts of
H. petiolare on normal Vero cells at concentration ranges of 12.5–200 µg/mL, using the
micronucleus assay [22]. In another study, the 90% methanol and dichloromethane (DCM)
extracts of H. petiolare were screened for aflatoxin B1-induced mutagenicity using the
bacteria-based genotoxic Ames and Vitotox assays [23]. The methanol extract showed
significant dose-dependent anti-mutagenic activity against S. typhimurium TA100 and TA 98
while the DCM extract had moderate anti-mutagenic effects against S. typhimurium TA 100
and more severe effects against S. typhimurium TA 98. Cancer remains a global disease today
with high mortality and morbidity rate. Mutagens are known to promote the pathogenesis
of most cancers via gene mutation and chromosomal aberration and anti-mutagens are
known to prevent chromosomal translocation, deletion and inversion [22,23]; hence the use
of H. petiolare extracts as food supplements could serve as potential carcinoprotection agents,
especially cancers induced by aflatoxin-producing fungi, in poorly-processed food crops.
3.7. Anti-Tyrosinase Activity of H. petiolare
A number of skin disorders are known to be promoted by anomalies in such implicated
enzymes as tyrosinase and elastase, in the face of damaging free radical effects on the
skin [24]. Therefore, compounds that inhibit such enzymes (e.g., tyrosinase inhibitors)
could potentially be very useful in the cosmetic industry to prevent skin aging and other
undesirable skin conditions [25,26]. H. petiolare plant extracts have been investigated
for their tyrosinase inhibition activities (25 ), and results obtained showed moderate
tyrosinase inhibition values of 44.3% and 59.2% at 50 µg/mL and 200 µg/mL concentrations
respectively, using kojic acid as the reference control [25]. The results obtained tend to
suggest that phytochemicals from the extracts of H. petiolare could inhibit free radical
accumulation and modulate tyrosinase activity.
In another study, treatment with the ethanol extract of H. petiolare was found to be non-
toxic to human dermal fibroblast (MRHF) cells using the Hoechst 3342/propidium iodide
stain and resulted in decreased ROS and NO production following lipopolysaccharide-
induced damage in the RAW 246.7 cell line. Additionally, weak inhibitory effects of the
extract on the enzymes of collagenase, elastase and tyrosinase at various concentrations
was reported in another study, compared to the positive control. In addition, this plant
extract effectively inhibited protein glycation, indicating its potential use as an anti-aging
agent for the skin [27].
4. Helichrysum cymosum and Its Biological Activities
Helichrysum cymosum (H. cymosum) is a plant endemic to South Africa and known
commonly as “gold carpet” or “yellow-tipped strawflower” in English. Its local South
African names include “goue tapyt” (in Afrikaans) and “impehho” (in isiXhosa). This plant
is widely distributed in the Eastern Cape, KwaZulu-Natal, and Western Cape Provinces,
and grows as a short, wooly shrub with grayish silver leaves and bright yellow-colored
flowers in flat heads. This species is divided into two subspecies, namely the H. cymosum
subsp. cymosum and H. cymosum subsp. calvum Hilliard [28,29], with distinct characteristics
in the flowers, fimbrils, ovary, pappus, and plant length [29]. Traditionally, the aerial parts,
leaves, roots, and leaves of this plant are used to treat different ailments ranging from cough,
catarrh, colds, headache, menstrual pain, fever, wounds, flatulence, pulmonary problems,
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skin infections, pertussis vomiting as well as to improve immunity, and appetite [15,29].
The reported biological and pharmacological activities of H. cymosum include anti-bacterial,
anti-fungal, anti-inflammatory, anti-malarial, anti-oxidant, and cytotoxic effects [15,29],
some of which are briefly discussed below.
4.1. Cytotoxicity of H. cymosum
Vuuren et al. investigated the toxicity of the essential oil and acetone extract of H.
cymosum as well as one of its isolated compounds, helihumulone on the transformed
kidney epithelial cell line, using the tetrazolium-based cell proliferative or viability assay
(MTT) [30]. The results showed that the essential oil was the most toxic extract, with
an IC50 value of 17.47 ± 33.0 µg/mL compared to 172.2 ± 10.08 µg/mL for the acetone
extract and 57.05 ± 3.04 µg/mL for helihumulone, respectively. In another study, the
cytotoxic effects of H. cymocum on the kidney Vero cell line were evaluated using the
XTT assay with varying concentrations of different solvent extracts of the plant: 3.13,
6.25, 12.50, 25.00, 50.00, 100.00, 200.00 and 400.00 µg/mL. These results showed that
compared to the positive control Zearlenone, with an IC50 value of 1.33 ± 0.32 µg/mL, the
chloroform extract (IC50 value 36.52 ± 0.27 µg/mL) was more toxic to the Vero cells than
the methanol-water (50% water/methanol and 50% chloroform) extract with an IC50 value
59.74 ± 0.14 µg/mL [31].
4.2. Anti-Oxidant Activity of H. cymosum
Francois (2016) investigated the anti-oxidant capacity of the essential oils isolated
from H. cymosum leaves using the 1, 1 diphenyl 1- picrylhydrazyl (DPPH) assay. Results
obtained showed that 50% free radical scavenging activity was achieved by the 6.3 g/L
concentration of this plant compared to the same effects by the 7.0 mg/L concentration of
the positive control, butylated hydroxytoluene (BHT), a known compound used as a food
anti-oxidant additive [29]. Thus, the extract of this plant had more anti-oxidant effects than
BHT, indicating potential use as food additives. No other anti-oxidant studies involving H.
cymosum were found in the literature at the time of writing this review, hence more studies
are recommended.
4.3. Anti-Malarial Activity of H. cymocum
Vuuren et al. reported on the anti-plasmodium activity of the acetone crude extract, the
essential oil, and the isolated compound helihumulone from H. cymocum on the falciparum
parasite, relative to the effects of two standard anti-malaria drugs (quinine and chloroquine).
The results from the G3-H hypoxanthine incorporation assay showed that when compared
to the two standard anti-malarial drugs, quinine (IC50 value 0.13 ± 0.04 µg/mL) and
chloroquine (IC50 value 0.09 ± 0.02 µg/mL), the essential oils had the least IC50 value
(1.25 ± 0.77 µg/mL) followed by helihumulone (14.89± 1.88 µg/mL) and then the acetone
crude extract (60.76 ± 2.83 µg/mL). Considering the relatively low IC50 value of the
essential oils of H. cymocum, their potential use as natural sources of anti-malarial treatment
agents is plausible [30].
4.4. Anti-Fungal Activity of H. cymocum
The anti-fungal activity of the essential oil and acetone extract of H. cymocum as well as
the isolated compound, helihumulone against C. neoformans and C. albicans was investigated
using the microdilution technique, with a potent anti-fungal agent amphotericin B as the
positive control. The MIC values used ranged from 0.03–4.0 mg/mL, and the results
showed that the 0.03 mg/mL and 0.063 mg/mL MICs of the helihumulone were the most
potent against C. neoformans and C. albicans [32]. Another study on the anti-fungal activity
of the isolated essential oils of H. cymocum showed that over 50% zone of inhibition was
achieved against Penicillium oxalicum while a 6 mm to 9 mm area of inhibition was reported
for C. albicans [33,34].
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4.5. Anti-Bacterial Activity of H. cymocum
Bougatsosa et al. reported on the anti-bacterial activities of the essential oils of
H. cymocum against the Gram-positive bacteria S. aureus and S. epidermis as well as four
Gram-negative bacteria, E. coli, Enterobacter cloacae, K. pneumoniae and Pseudomonas aerug-
inosa. The MIC results from the dilution technique showed that the essential oils of
H. cymocum were not sensitive (completely inactive) to all the bacteria strains tested when
compared to the essential oils of a closely-related plant species H. fulgidum (L.) Wild, which
have been reported to be highly sensitive to the same bacterial strains tested [34]. Similar
studies by Sindambiwe et al. showed that the 80% ethanol extract of H. cymocum was
not sensitive to the bacteria Proteus vulgaris, E. coli, K. pneumoniae, P. aeruginosa, Salmonella
paratyphi, B. cereus, Mycobacterium fortuitum and S. aureus, whereas Streptococcus pyogenes
showed a MIC value of 5 mg/mL which indicates some sensitivity [35]. The results
of another anti-bacterial activity study using the disc diffusion assay showed a zone of
inhibition value of 7 mm and 5 mm respectively for S. aureus, 8 mm and 5 mm respec-
tively for B. cereus, and no inhibition by the essential oils [32]. In yet another study, the
isolated compound helihumulone, was found to have the highest anti-bacterial activity
against the bacteria Enterococcus faecalis, B. cereus, B. subtilis, S. aureus, P. aeruginosa, E. coli,
Y. enterocolitica, and K. pneumonia at the concentration range of 0.02–0.12 mg/mL, using the
p-iodo nitro tetrazolium (INT) microplate method, when compared with the essential oil
(1.0–8.0 mg/mL) and acetone extract (0.1–0.3 mg/mL) of H. cymocum. The acetone extract
activity was reported to be six times more than that of the essential oils [33].
4.6. Anti-Inflammatory Activity of H. cymocum
Standford and co-workers investigated the inhibitory effects of the ethanol and aque-
ous extracts of H. cymocum to prostaglandin, a known marker of inflammation, using
the in vitro cyclooxygenase assay. The results showed that, whereas the standard anti-
inflammatory drug indomethacin showed 60% inhibition, the aqueous extract showed
52% and the ethanol extract showed 100% inhibitory activity [36]. In addition, other
related plant species like Helichrysum excisum and Helichrysum felinum were reported to
exhibit anti-inflammatory properties; the acetone extract and essential oil from H. excisum
showed anti-inflammatory properties at IC50 concentrations of 35.09 ± 1.12 µg/mL and
27.62 ± 0.43 µg/mL respectively, using the 5-lipoxygenase assay, while the anti-inflammatory
properties reported for the acetone extract and essential oil from H. felinum, occurred at IC50
concentrations of 38.72 ± 2.94 µg/mL and 22.87 ± 7.59 µg/mL respectively, in comparison
with control with IC50 of 5.00 ± 0.50 µg/mL [37].
4.7. Anti-Viral Activity of H. cymocum
The virucidal activity of the ethanol extract of H. cymocum against selected viruses was
studied using the 50% endpoint titration technique (EPTT). This assay involves the deter-
mination of virus titer reduction in the presence of two-fold dilutions of test compounds on
monolayers of cells grown in plastic or glass Petri dishes [38]. The results obtained showed
that the extract was effective against the simplex virus type 1 (HSV1), the measles virus
strain Edmonston A (MV-EA) as well as the Semliki forest virus A7 (S.F. A7) [35]. In addi-
tion, the anti-viral bioactivity of the methanol/water and chloroform (50% water/methanol
and 50% chloroform) extracts of the aerial parts of H. cymocum were investigated in one
study using colorimetric cell-based, a cytopathic effect inhibition assay. The results showed
cytopathic effects against Vero cells at a final toxic concentration of 400 µg/mL, compared
with the positive control acyclovir with anti-viral activity of 0.75 µg/mL [31].
5. Helichrysum foetidum and Its Biological Activities
H. foetidum is a robust herb commonly referred to as the stinging starflower with a
characteristic pungent smell. Its leaves are elliptic, sparsely hairy, white-woolly, and are
arranged in groups at the base of the stem while its many flower heads are borne in broad,
leafy spreading umbrella-like inflorescences [39]. This plant is native to South Africa and
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has since been introduced to other parts of the world, including Spain, Portugal, and South-
ern Brazil [40]. H. foetidum is used in African tradomedical practices to induce a trance,
mainly due to its hallucinatory effects. It is also used for the treatment of wounds, for
dressing the circumcised penis in traditional ceremonies, for infected sores, for menstrual
pains, herpes, eye infection, influenza, among other ailments [39]. The chemical com-
position of H. foetidum includes diterpenoid, Kaur-16-en-18-oic acid, flavonoid, apigenin
7,4 O-dihydroxy-5-methoxy-flavanone, apigenin 7-O- β-D- glucoside and 6-methoxy-2′,
4,4-trihydroxy-chalcone helichrysetins, as well as glucosylated helichrysins [41]. Its bio-
logical activities include anti-bacterial [42], anti-fungal [43], anti-viral [35], antioxidant,
anti-ulcerogenic, and cytotoxic effects [43].
5.1. Cytotoxicity of H. foetidum
The in vitro cytotoxic effects of the isolated compounds of H. foetidum on the human
prostate cancer cell line (PC-3) were evaluated using the XTT assay. These compounds were
found to have no effects on PC-3 viability at the concentrations. It was reported that the
compound reduced the viability of cancer cells and induced apoptosis at the concentrations
of 50 nM or 50 µM of the isolated compound [42]. In another study, the transformed
human kidney epithelial (Graham’s) cells, MCF-7 breast adenocarcinoma cells, and SF-268
glioblastoma cells were reported to be sensitive to the leaf and stem extracts of chloroform
and methanol (solvent ratio 1:1), with a significant reduction in cell viability (24.9%) in
MCF-7 cells, at a concentration of 0.1 mg/mL of the extract [18].
5.2. Anti-Ulcerogenic Properties of H. foetidum
Malolo et al. reported on the potential of the methanol extract and the isolated com-
pounds from H. foetidum, to inhibit the enzyme protease, through the in vitro protease
pepsin inhibition assay known as the fluorescence resonance energy transfer (FRET) as-
say [43]. Pepsin is the main acid protease of the stomach and is implicated in peptic ulcer
disease, reflux oesophagitis, and excessive stomach acid secretion, although Helicobacter
pylori bacteria are also involved in the pathogenesis of most gastric diseases. Following
treatment with the methanol extract of H. foetidum, the FRET assay showed 17.8%, 35.6%
and 37.6% inhibitory activity against pepsin at the concentrations of 10 µg/mL, 25 µg/mL
and 50 µg/mL, respectively; however, no action was detected against subtilisin, a known al-
kaline protease [43,44]. Furthermore, out of the six isolated compounds tested in this study,
only apigenin-7-β-D-glucoside and 6′ methoxy-2′,4 dihydroxychalcone-4′-O-β-D-glucoside
showed moderate inhibition range of 37.4% to 46.3% at 50 µg/mL concentration [43].
5.3. Anti-Bacterial Activity of H. foetidum
Steenkamp et al. (2014) investigated the anti-bacterial activity of the methanol, and
aqueous extracts of H. foetidum against S. aureus, S. pyrogenes, E. coli, and P. aeruginosa,
and the results showed a MIC value of not more than 4 mg/mL in all the bacterial strains
tested [45]. In addition, the anti-bacterial activity of the methanol extract and six isolated
compounds from H. foetidum against B. subtilis bacteria was evaluated in another study,
using a fluorescence-based anti-bacterial inhibition assay [43]. The results obtained showed
MIC values of 85.4% and 21.8% for the methanol extract, at the concentration range of
1.0 mg/mL and 0.1 mg/mL respectively, while the isolated compounds displayed growth
inhibition in the range of 75.0% to 85.0%.
5.4. Anti-Fungal Activity of H. foetidum
Cladosporium cucumerrinum is a known fungus that causes diseases in plants, leading to
reduced crop yield. The in vitro anti-fungal activity of the methanol extract and six isolated
compounds from H. foetidum against this pathogen was reported [45]. The concentrations
of 50 µg/cm, 100 µg/cm, 200 µg/cm and 400 µg/cm of the methanol extract of Helichrysum
foetidum used in a bioautograpy assay on silica gel plates, indicated that zones of growth
inhibition against the fungus were well developed on bioautograpy plate, showing a
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significant anti-fungal property [45]. All the six isolated compounds showed growth
inhibition against C. cucumerrinum in the range of 70% to 56% at 1.0 mg/mL concentrations
in the assay [45].
5.5. Anti-Oxidant Activity of H. foetidum
Bruno et al. reported the anti-oxidant activity of the methanol extract of H. foetidum
using an array of in vitro assays [46], including the 2-2’ azinobin-3-ethlbenzothiazoline-6-
sulphonic acid (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging, and
the β-carotene/linoleic acid assay. The anti-oxidant activity of the methanol extract of H.
foetidum determined by the ABTS and DPPH assays, occurred at the IC50 concentrations of
0.5 ± 0.1 µg, 0.6 ± 0.1 µg, and 1.5 ± 0.3 µg respectively, compared with the known anti-
oxidant compounds, Trolox or BHT, used as the standards, with IC50 values of 1.3 µg and
1.5 µg respectively. On the other hand, the scavenging of hydrogen peroxide (HRPO) test,
the superoxide anion scavenging (SAS) test and the hypochlorous acid scavenging (taurine)
test showed anti-oxidant activity at IC50 concentrations of 15.0 ± 2.0 µg, 34.0 ± 6.0 µg,
and 24.0 ± 3.0 µg respectively. The anti-oxidant activity of medicinal plants is commonly
attributed to the presence of phenols, flavonoids, flavanols, and oligomeric proantho-
cyanidins, which in this study, were quantified to be 580 ± 87 mg/g, 460 ± 69 mg/g,
12 ± 2 mg/g, and 5 ± 1 mg/g respectively, in the methanol extract of H. foetidum [46].
5.6. Anti-Viral Activities of H. foetidum
The 50% endpoint titration technique (50% EPTT) was adopted by Sindambiwe et al.
(1999) to evaluate the anti-viral activities of the aqueous and 80% ethanol extracts of the
whole plant parts of H. foetidum. Virucidal activities against HSV1 and the Semliki Forest
virus A7 (SFA7) were reported but not against the measles virus strain Edmonston A
(MV-EA) and the vesicular stomatitis virus T2 (VSVT2) [35].
6. Helichrysum pandurifolium Schrank and Its Biological Activities
The common name of H. pandurifolium Schrank is Hottentotskruie or Hottentotskooigoed
or fiddle leaf-strawflower, with the stem and leaf parts often prepared as infusions for the
traditional treatment of such ailments as respiratory conditions, cough, heart conditions,
kidney stones and other kidney-related conditions [10]. The plant is a tall, slender, loosely-
branched and soft shrub with orbicular-to-ovate leaves that abruptly narrow at a broad
petiole-like base. The flowers are yellow, with the outer and inner parts of the involucre
bracts being light-brown and white-pink, respectively. The apex of this herbal plant is
sharp, while its fruits have a pappus with an array of feathery bristles [14,40].
Currently, information on the phytochemicals and pharmacological actions of
H. pandurifolium Schrank is scanty in the literature, a possible indication that this species is
not well-studied scientifically.
7. Common Phytochemicals Present in the Selected Helichrysum Species
Phytochemicals refer to structurally diverse secondary metabolites or compounds that
are produced by plants or non-pathogenic endophytic microorganisms in plants, to serve
a protective role against any form of insults by pathogens (bacteria, fungi and viruses),
through participation in the body’s anti-oxidant defensive and protective mechanisms such
as free-radical scavenging [47,48]. Phytochemicals, therefore, confer essential pharmaco-
logical or biological functions on medicinal plants. In 1967, phytochemical studies of the
helichrysum genus were done, and the helichrysum dendroideum species was the first to
be explored [49], leading to the identification of many chemical secondary metabolites.
Scientific reports on 63 helichrysum species of South African origin have shown many
isolated compounds, including acylphloroglucinol, humulone derivatives, flavonoids,
8-hyroxyflavonols, α-pyrones, chalcone, and pyranochalcones [37,50,51]; essential oils, ben-
zofurans, oxygenated compounds are present in the many species of this plant genus [10].
Representative of some of the compounds present in H. petiolare, H. cymosum, H. foetidum
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and H. pandurifolium Schrank are depicted in Figures 1–4. While the biological functions
of the associated compounds including that of the essential oils are listed in Tables 1–5 in
this review.
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Table 1. Description of bioactivity of the compounds of Helichrysum cymosum.
Compounds Biological Functions
Helihumulone anti-bacterial and anti-mycotic [15,52]
(Z)-β-ocimene Molluscidal and leshimanicidal agents [53]
Trans-caryophyllene Anti-malarial [15,36]
1, 8-cineole Anti-inflammatory, antioxidant, anticancer, analgesic [54]
α-humulene Anti-Proliferative [55]
(E)-β-ocimene Molluscidal and leshimanicidal agents [53]
Caryophyllene oxide Anti-malarial [15,36]
β-caryophyllene Anti-malarial [15,36]
∆-3-carene AChE inhibition, anti-inflammatory Anti-fungal [56,57]
5-hydroxy-8-methoxy-7-
prenyloxyflavanone Anti-viral [30]
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Figure 3. Structures of phytochemicals isolated from Helichrysum cymosum.
Table 2. Description of bioactivity of the compounds Helichrysum foetidum.
Compounds Biological Functions
6′-methoxy-2′, 4, 4′-trihydroxychalcone Anti-bacterial, anti-fungal, anti-ulcerogenic [43]
6′-methoxy-2′,4-dihydroxychalcone- 4′-O-β-D-glucoside Anti-bacterial, anti-fungal, anti-ulcerogenic [43]
Kaur-16-en-18-oic acid Anti-bacterial, anti-fungal, anti-ulcerogenic [43]
Apigenin Anti-bacterial, anti-fungal, anti-ulcerogenic [43]
Apigenin-7-O-β-D-glucoside Anti-bacterial, anti-fungal, anti-ulcerogenic [43]
7,4′-dihydroxy-5-methoxy-flavanone Anti-bacterial, anti-fungal, anti-ulcerogenic [43]
4,5 –diacaffeoyl quinic acid Anti-bacterial, anti-fungal, anti-ulcerogenic [43]
Ferulic acid Anti-inflammatory, anti-oxidant, anti-diabetic,anti-hypertensive [58]
Chlorogenic acid Anti-oxidant, anti-inflammatory, Anti-bacterial, anti-mutagenicand anti-cancer [59]
Campest-7-en-3-ol Anti-bacterial, antifungal, anti-ulcerogenic [43]
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Table 3. Description of bioactivity of the compounds of Helichrysum petiolare.
Compounds Biological Functions
Alloaromadendrene Anti-microbial, anti-viral, anti-diabetic, anti-inflammatory [60]
δ-Selinene anti-fungal [61]
Phenol, 2-ethoxy-5- (1, 2-dihydroxyethyl) - N/A
Phytol Anti-oxidant, anti-microbial, anti-convulsant, cytotoxic,anti-inflammatory [62]
Ledol N/A
α-Calacorene Anti-microbial, anti-oxidant [63]
β-Hydroagarofuran Anti-bacterial and anti-mycotic [15]
Spathulenol Anti-inflammatory, anti-nociceptive [64,65]
α-Bulnesene A ti-platelet aggregation agent [66]
δ-Cadinene Anti-malarial [67]
Not available: N/A.
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Table 4. Description of bioactivity of the compounds of H. pandurifolium.
Compounds Biological Functions








Germacrene d-4-ol N/A [14]
1,8-cineole N/A [14]
Not available: N/A.
8. Essential Oils Present in Selected Helichrysum Species
Essential oils (EOs) are the condensed or concentrated hydrophobic liquids that
contain volatile chemical compounds derived from plants. The variety of compounds in
EOs depends on such factors as the plant species, plant part used (leaves, fruits, roots),
harvest period, environmental conditions (land fertility, humidity, temperature) and the
extraction technique employed [68].
One distinct characteristic of the helichrysum genus is its aromatic nature and most of
the species in this genus have been reported to be rich in essential oils (EOs) containing
many compounds [10]. Many EOs are prescribed as alternative medicine (in aromatherapy)
based on the healing effects of their aromatic compounds [69]. Monoterpenes, sesquiter-
penes and diterpenes are some of the broad groups of compounds present in the EOs of
most plants, including the helichrysum genus; these compounds are largely responsible
for the reported anti-fungal, anti-bacterial, anti-diabetic, anti-inflammatory, anti-ulcer,
anti-cancer, anti-oxidant, anti-nociceptive, and anti-spasmodic properties associated with
these plants.
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Table 5. The common phytochemical compounds present in the essential oils of selected Helichyrsum species.
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9. Conclusions
Plants belonging to the Helichrysum genus are a vital source of traditional medicines
in many parts of the world, including South Africa. The many novel chemical compounds
present in the extracts of these plants and their essential oils account for most of their
pharmacological actions. This review highlighted the reported diversity of the Helichrysum
genus and the ethnomedicinal and biological activities of some of its species. However, only
limited scientific reports are available in the literature on some species, hence further multi-
disciplinary studies by botanists, chemists, ethnopharmacologists and medical scientists
are required on all the plants in this genus, as they appear to be potential sources of
useful bioactive medicinal compounds that could be exploited in the drug discovery and
development value chain.
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